期刊
CONTEMPORARY CLINICAL TRIALS
卷 36, 期 2, 页码 651-663出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.cct.2013.08.007
关键词
Adaptive randomization; Biomarker classifiers; Generalized likelihood ratio statistics; Group sequential design; Multiple testing; Targeted therapies
资金
- NSF [DMS-1106535]
- NIH [1 P30 CA124435-01]
- Division Of Mathematical Sciences
- Direct For Mathematical & Physical Scien [1106535] Funding Source: National Science Foundation
Biomarker-guided personalized therapies offer great promise to improve drug development and improve patient care, but also pose difficult challenges in designing clinical trials for the development and validation of these therapies. We first give a review of the existing approaches, briefly for clinical trials in new drug development and in more detail for comparative effectiveness trials involving approved treatments. We then introduce new group sequential designs to develop and test personalized treatment strategies involving approved treatments. (C) 2013 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据